A5023277921- Transplantation: Methods and Outcomes
- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Innovations in Medical Education
- Surgical Simulation and Training
- Nitric Oxide and Endothelin Effects
- Cardiac Valve Diseases and Treatments
- Cardiac Imaging and Diagnostics
- Kawasaki Disease and Coronary Complications
- Health and Medical Research Impacts
- CNS Lymphoma Diagnosis and Treatment
- Aortic Disease and Treatment Approaches
- Neurological Complications and Syndromes
- Healthcare Policy and Management
- Coronary Interventions and Diagnostics
- Aortic aneurysm repair treatments
- Ultrasound and Hyperthermia Applications
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Function and Risk Factors
- Autoimmune and Inflammatory Disorders Research
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Issues in Pregnancy
- Advanced MRI Techniques and Applications
- Innovation Policy and R&D
Stanford University
2024
University of California, Los Angeles
2020-2024
Ronald Reagan UCLA Medical Center
2024
Abstract Background The new United Network for Organ Sharing (UNOS) heart allocation policy prioritizes temporary percutaneous over durable left ventricular assist devices (LVAD) as bridge to transplant. We sought examine 1‐year outcomes of transplant recipients bridged with Impella versus LVADs. Methods All primary adult orthotopic registered in UNOS between January 2016 and June 2021 were analyzed. Recipients identified being isolated or LVAD at the time Baseline characteristics compared...
Aortic valve replacement improves survival for patients with low-gradient aortic stenosis, but there is a paucity of data on postoperative quality life this population.In single-center retrospective analysis 304 severe stenosis who underwent transcatheter replacement, were divided into 4 groups based mean pressure gradient, left ventricular ejection fraction, and stroke volume index. Using the Kansas City Cardiomyopathy Questionnaire-12, was assessed immediately before 1 month after...
Objective Unrecognized left ventricular thrombi (LVT) can have devastating clinical implications and precludes patients with end-stage heart failure from undergoing assist device (LVAD) implantation without cardiopulmonary bypass assistance. We assessed the reliability of an echocardiogram to diagnose LVT in disease who underwent LVAD implantation. Methods A single-center retrospective study evaluated 232 consecutive adult requiring durable LVADs between 2005 2019. The validity preoperative...
Central MessageRecurrent infections post-LVAD explantation should not be dismissed as mere of the skin driveline interface. Although rare, retained velour must considered a possible etiology. Left ventricular assist devices (LVADs) are commonly used bridges to transplantation.1Bowen R.E.S. Graetz T.J. Emmert D.A. Avidan M.S. Statistics heart failure and mechanical circulatory support in 2020.Ann Transl Med. 2020; 8: 827https://doi.org/10.21037/atm-20-1127Crossref PubMed Google Scholar...